ZyVersa Therapeutics, Inc. (ZVSA)

CIK 1859007 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ZyVersa Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Jul 16, 20268-K0001493152-26-033565
Jul 10, 20268-K0001493152-26-032851
May 13, 202610-Q0001493152-26-022759
Mar 31, 202610-K0001493152-26-014271
Mar 5, 20268-K0001493152-26-008994
Dec 3, 20258-K0001493152-25-025966
Nov 19, 202510-Q0001493152-25-024263
Nov 19, 20258-K0001493152-25-024273
Nov 14, 2025NT 10-Q0001493152-25-023612
Oct 15, 20258-K0001493152-25-018156
Oct 6, 202525-NSE0001354457-25-000988
Sep 18, 20258-K0001493152-25-013968
Aug 14, 2025SCHEDULE 13G/A0001172661-25-003603
Aug 13, 202510-Q0001641172-25-023342
Aug 6, 2025EFFECT9999999995-25-002497
Aug 1, 2025S-1/A0001641172-25-021952
Jul 28, 20258-K0001641172-25-021100
Jul 18, 2025S-1/A0001641172-25-020253
Jul 16, 20258-K0001641172-25-019856
Jul 16, 202540001641172-25-019858
Jul 15, 202540001641172-25-019725
Jul 15, 202540001641172-25-019727
Jul 15, 202540001641172-25-019724
Jul 15, 202540001641172-25-019723
Jul 15, 202540001641172-25-019728